BMT — Coolan Income Statement
0.000.00%
HealthcareMicro Cap
Annual income statement for Coolan, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.
R2020 June 30th | 2021 June 30th | R2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | fx Final | fx Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 68.5 | 56.6 | 39.9 | 28.2 | 7.1 |
Cost of Revenue | |||||
Gross Profit | 29.7 | 22.7 | 18.2 | 12.8 | 0.878 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 70.3 | 54.8 | 85.9 | 35 | 6.42 |
Operating Profit | -1.81 | 1.84 | -46 | -6.72 | 0.688 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -2.97 | 0.615 | -47 | -7.62 | 0.333 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.6 | 0.078 | -47.4 | -8 | 0.326 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -12.4 | -25.8 | -47.7 | -7.91 | 0.453 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.4 | -25.8 | -47.7 | -7.91 | 0.453 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.023 | -0.007 | -0.208 | -0.021 | -0.005 |